InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: Titan V post# 38448

Thursday, 02/23/2017 8:32:43 PM

Thursday, February 23, 2017 8:32:43 PM

Post# of 48316
Hey Titan. I believe they will begin the registration trial on the basis of current data. It is a good thing that the subset of 9 failed anti-pd-1 patients (33%) are showing a response or we might have a problem. The change in trial protocol last fall really shook things up so there is alot of hope and fingers crossed that more positive data comes out of that protocol change. Any more evidence to show absolute anti-pd-1 failures are responding to treatment will go a long way with market confidence heading into the registration trial...meaning institutional investment, partnership dollars etc. We don't need more dilution here, we need confidence and money. Merck is it. They give us the cash nod and we are solid gold. It is tough to see them spread the wealth to other companies and we have been waiting on Oncosec to get their due respect.